Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Exercise testing: the catecholaminergic polymorphic ventricular tachycardia crystal ball?

Sy RW, Krahn AD.

Europace. 2012 Sep;14(9):1225-7. doi: 10.1093/europace/eus146. Epub 2012 May 7. No abstract available.

PMID:
22565054
[PubMed - indexed for MEDLINE]
Free Article
2.

The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands.

Hayashi M, Denjoy I, Hayashi M, Extramiana F, Maltret A, Roux-Buisson N, Lupoglazoff JM, Klug D, Maury P, Messali A, Guicheney P, Leenhardt A.

Europace. 2012 Sep;14(9):1344-51. doi: 10.1093/europace/eus031. Epub 2012 Mar 1.

PMID:
22383456
[PubMed - indexed for MEDLINE]
Free Article
3.

Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia.

Marjamaa A, Hiippala A, Arrhenius B, Lahtinen AM, Kontula K, Toivonen L, Happonen JM, Swan H.

J Cardiovasc Electrophysiol. 2012 Feb;23(2):194-9. doi: 10.1111/j.1540-8167.2011.02188.x. Epub 2011 Sep 28.

PMID:
21954897
[PubMed - indexed for MEDLINE]
4.

Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.

Swan H, Laitinen P, Kontula K, Toivonen L.

J Cardiovasc Electrophysiol. 2005 Feb;16(2):162-6.

PMID:
15720454
[PubMed - indexed for MEDLINE]
5.

Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.

Allouis M, Probst V, Jaafar P, Schott JJ, Le Marec H.

Am J Cardiol. 2005 Mar 1;95(5):700-2.

PMID:
15721128
[PubMed - indexed for MEDLINE]
6.

High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.

Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP.

Europace. 2010 Mar;12(3):417-23. doi: 10.1093/europace/eup448. Epub 2010 Jan 26.

PMID:
20106799
[PubMed - indexed for MEDLINE]
Free Article
7.

A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.

Aizawa Y, Ueda K, Komura S, Washizuka T, Chinushi M, Inagaki N, Matsumoto Y, Hayashi T, Takahashi M, Nakano N, Yasunami M, Kimura A, Hiraoka M, Aizawa Y.

Int J Cardiol. 2005 Mar 18;99(2):343-5.

PMID:
15749201
[PubMed - indexed for MEDLINE]
8.

Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.

Diffley M, Armenian P, Gerona R, Reinhartz O, Avasarala K.

Crit Care Med. 2012 Jul;40(7):2223-6. doi: 10.1097/CCM.0b013e318250a870.

PMID:
22584762
[PubMed - indexed for MEDLINE]
9.

Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.

Napolitano C, Priori SG.

Heart Rhythm. 2007 May;4(5):675-8. Epub 2007 Jan 7. Review. No abstract available.

PMID:
17467641
[PubMed - indexed for MEDLINE]
10.

Deadly proposal: a case of catecholaminergic polymorphic ventricular tachycardia.

Heiner JD, Bullard-Berent JH, Inbar S.

Pediatr Emerg Care. 2011 Nov;27(11):1065-8. doi: 10.1097/PEC.0b013e3182360606.

PMID:
22068070
[PubMed - indexed for MEDLINE]
11.

Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT).

Aizawa Y, Komura S, Okada S, Chinushi M, Aizawa Y, Morita H, Ohe T.

Int Heart J. 2006 May;47(3):381-9.

PMID:
16823244
[PubMed - indexed for MEDLINE]
Free Article
12.

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.

Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A.

Circulation. 2009 May 12;119(18):2426-34. doi: 10.1161/CIRCULATIONAHA.108.829267. Epub 2009 Apr 27.

PMID:
19398665
[PubMed - indexed for MEDLINE]
Free Article
13.

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A.

Circulation. 2002 Jul 2;106(1):69-74.

PMID:
12093772
[PubMed - indexed for MEDLINE]
Free Article
14.

A novel mutation (Arg169Gln) of the cardiac ryanodine receptor gene causing exercise-induced bidirectional ventricular tachycardia.

Hsueh CH, Weng YC, Chen CY, Lin TK, Lin YH, Lai LP, Lin JL.

Int J Cardiol. 2006 Apr 4;108(2):276-8.

PMID:
16517285
[PubMed - indexed for MEDLINE]
15.

An unusual catecholaminergic polymorphic ventricular tachycardia not inducible at stress test.

Brunetti ND, De Gennaro L, Gaglione A, Di Biase M.

Int J Cardiol. 2011 Dec 15;153(3):e54-5. doi: 10.1016/j.ijcard.2011.02.044. Epub 2011 Mar 12. No abstract available.

PMID:
21397961
[PubMed - indexed for MEDLINE]
16.

Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction Registry.

Krahn AD, Healey JS, Chauhan VS, Birnie DH, Champagne J, Sanatani S, Ahmad K, Ballantyne E, Gerull B, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Klein GJ, Gollob MH, Simpson CS, Talajic M, Gardner M.

Circ Arrhythm Electrophysiol. 2012 Oct;5(5):933-40. doi: 10.1161/CIRCEP.112.973230. Epub 2012 Sep 3.

PMID:
22944906
[PubMed - indexed for MEDLINE]
Free Article
17.

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.

Rosso R, Kalman JM, Rogowski O, Diamant S, Birger A, Biner S, Belhassen B, Viskin S.

Heart Rhythm. 2007 Sep;4(9):1149-54. Epub 2007 May 24.

PMID:
17765612
[PubMed - indexed for MEDLINE]
18.

Catecholaminergic polymorphic ventricular tachycardia caused by a novel mutation in the cardiac ryanodine receptor.

Hasdemir C, Aydin HH, Sahin S, Wollnik B.

Anadolu Kardiyol Derg. 2008 Oct 16;8(5):E35-6. No abstract available.

PMID:
18849218
[PubMed - indexed for MEDLINE]
Free Article
19.

Clinical characteristics and mutational analysis of the RyR2 gene in seven Czech families with catecholaminergic polymorphic ventricular tachycardia.

Andrsova I, Valaskova I, Kubus P, Vit P, Gaillyova R, Kadlecova J, Manouskova L, Novotny T.

Pacing Clin Electrophysiol. 2012 Jul;35(7):798-803. doi: 10.1111/j.1540-8159.2012.03399.x. Epub 2012 Apr 22.

PMID:
22519458
[PubMed - indexed for MEDLINE]
20.

Catecholaminergic polymorphic ventricular tachycardia.

Francis J, Sankar V, Nair VK, Priori SG.

Heart Rhythm. 2005 May;2(5):550-4. Review.

PMID:
15840485
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk